Mount Sinai Morningside · 3 months ago
Postdoctoral Fellow-MSH-30030-274
Mount Sinai Morningside is seeking a highly motivated Postdoctoral Fellow to investigate virus–host interactions that drive pathogenesis, focusing on airway biology and antiviral defense. This role involves leading independent and collaborative projects and applying various advanced techniques in virology and cell biology.
Hospital & Health Care
Responsibilities
Lead independent and collaborative projects on respiratory virus–host mechanisms
Apply molecular virology, advanced cell culture systems (ALI and iPSC-derived models), microscopy, proteomics, and in vivo mouse models
Analyze data, write manuscripts, and present at lab meetings and conferences
Help mentor students and contribute to a supportive lab culture
Qualification
Required
Ph.D. (or equivalent) in Virology, Immunology, Molecular/Cell Biology, or a related field
Strong foundation in molecular virology, cell biology, or immunology
Excellent communication skills; self-driven; team-oriented
Preferred
Preferred experience in one or more: respiratory viruses; cilia/airway epithelial models; microscopy; mouse models of infection
Benefits
Access to world-class core facilities at Mount Sinai.
A dynamic, international environment within the Global Health & Emerging Pathogens Institute.
Competitive salary and benefits aligned with NIH guidelines.
Strong mentorship and support for professional development.
Company
Mount Sinai Morningside
At Mount Sinai Morningside, we offer exceptional clinical care and research within the comfort of a neighborhood hospital known for compassion and sensitivity.
H1B Sponsorship
Mount Sinai Morningside has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (3)
2023 (26)
2022 (20)
2021 (6)
2020 (20)
Funding
Current Stage
Late StageLeadership Team
Company data provided by crunchbase